RankAlpha logo
Back to Rankings

PACS

PACS GroupD
NYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
View Chart

AI scenario view

RankAlpha Sentiment Codex
B+
Bull case
20%
Probability
Target price
$50.00
Analysis reference price unavailable
Analysis 2026-10-02 · RankAlpha Sentiment Codex
Most likely
B
Base case
45%
Probability
Target price
$41.00
Analysis reference price unavailable
Analysis 2026-10-02 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$30.00
Analysis reference price unavailable
Analysis 2026-10-02 · RankAlpha Sentiment Codex

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-10-02
Recent news sentiment (30D)
-26.0
Negative
Company
-
Unavailable
Macro
-26.0
Negative
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+37.3
Score

AI commentary

Company-reported Q2 performance and acquisition progress support a positive operating narrative, but the packet's deterministic directional prior is negative and acquisition execution remains unproven. PACS is a skilled-nursing operator; the packet's medtech classification does not justify device-approval or hospital-adoption catalysts. A verified recent price reaction, analyst revisions, options skew, short interest and sufficient social coverage were unavailable. Zero sentiment-field values denote unavailable observations, not measured neutral readings. [#SEC-8K-2026-08-04] [#IR-2026-09-01]

RankAlpha Sentiment Codex - 2026-10-02
Open full AI memo

Evidence flagged

report lacks a dated company-specific catalyst beyond generic cadence for its sector profile; peer set is too generic or lacks enough direct operating comparators

Impact
tentative
Confidence
-

AI events

2026-12-31eventExpected Q4 2026 Florida facility closingHigh impact

On September 1, PACS announced agreements to acquire operations of 32 Florida skilled-nursing facilities with 4,049 licensed beds. The company expects closing in Q4 2026, subject to conditions; it has not reported completion. Lease and integration economics will determine the value created. December 31 marks the end of the announced window, not a scheduled closing date. [#IR-2026-09-01] https://ir.pacs.com/news-events/press-releases/detail/138/pacs-group-to-acquire-operations-of-32-facilities-across-florida-and-closes-on-additional-previously-announced-eduro-facilities

2026-12-31eventRemaining Eduro facility closingsMedium impact

PACS reported on September 1 that 31 of 34 Eduro facilities had closed; three remained subject to closing conditions. Completion would expand the operating base, but returns depend on integrating the acquired facilities. [#IR-2026-09-01] https://ir.pacs.com/news-events/press-releases/detail/138/pacs-group-to-acquire-operations-of-32-facilities-across-florida-and-closes-on-additional-previously-announced-eduro-facilities

2026-12-31catalystDelivery against raised 2026 outlookMedium impact

Q2 revenue rose 9.1% to $1.43 billion, adjusted EBITDA rose 24.6% to $166.8 million, and same-store skilled-nursing occupancy reached 90.6%. PACS raised 2026 revenue guidance to $5.75–$5.85 billion and adjusted EBITDA guidance to $640–$660 million. Sustaining occupancy, skilled mix and margins as acquisitions ramp is the operating test. [#SEC-8K-2026-08-04] https://www.sec.gov/Archives/edgar/data/2001184/000200118426000031/pacsgroupincearningsreleas.htm

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-10-02 • Updated nightlySource: Internal modelMethodology